Shuntaro Ikawa
- Oncology top 1%
- Cancer-related Molecular Pathways 23
- Biotechnology top 0.5%
- Cancer Research and Treatments 14
- Cancer Research top 2%
- Carcinogens and Genotoxicity Assessment 6
- Molecular Biology top 2%
- RNA modifications and cancer 12
- Viral Infectious Diseases and Gene Expression in Insects 4
-
- Pharmacogenetics and Drug Metabolism 6
-
- Virus-based gene therapy research 5
-
- Animal Virus Infections Studies 4
- Co-authors
- Tadashi YamamotoKentaro SembaKumao ToyoshimaTetsu AkiyamaNobuo NomuraToshiyuki SaitoNobuyuki MiyajimaYoji Ikawa
- Cited by
- OncologyBiotechnologyCancer Research
- Partner nations
- JapanUnited StatesAustralia
In The Last Decade
Shuntaro Ikawa
69 papers receiving 4.6k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Oncology 2.4k
- Biotechnology 617
- Cancer Research 726
- Molecular Biology 2.8k
- Radiology, Nuclear Medicine and Imaging 547
Countries citing papers authored by Shuntaro Ikawa
This map shows the geographic impact of Shuntaro Ikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuntaro Ikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuntaro Ikawa more than expected).
Fields of papers citing papers by Shuntaro Ikawa
This network shows the impact of papers produced by Shuntaro Ikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuntaro Ikawa. The network helps show where Shuntaro Ikawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shuntaro Ikawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 15 | |
| 2 | 2018 | 55 | |
| 3 | 2017 | 12 | |
| 4 | 2015 | 19 | |
| 5 | 2015 | 15 | |
| 6 | 2013 | 16 | |
| 7 | 2010 | 77 | |
| 8 | 2008 | 32 | |
| 9 | 2007 | 19 | |
| 10 | 2006 | 18 | |
| 11 | 2005 | 33 | |
| 12 | 2003 | 19 | |
| 13 | 2000 | 73 | |
| 14 | 2000 | 32 | |
| 15 | 1999 | 47 | |
| 16 | 1998 | 65 | |
| 17 | 1995 | 3 | |
| 18 | 1994 | 2 | |
| 19 | 1994 | 91 | |
| 20 | 1994 | 10 |
About Shuntaro Ikawa
Shuntaro Ikawa is a scholar working on Biotechnology, Oncology and Cancer Research, having authored 70 papers that have together received 4.8k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (23 papers), Cancer Research and Treatments (14 papers), RNA modifications and cancer (12 papers), Pharmacogenetics and Drug Metabolism (6 papers), Carcinogens and Genotoxicity Assessment (6 papers), Virus-based gene therapy research (5 papers), Animal Virus Infections Studies (4 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). The work is most often cited by research in Oncology (2.4k citations), Biotechnology (617 citations) and Cancer Research (726 citations). Shuntaro Ikawa has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Tadashi Yamamoto, Kentaro Semba, Kumao Toyoshima, Tetsu Akiyama, Nobuo Nomura, Toshiyuki Saito, Nobuyuki Miyajima, Yoji Ikawa, Masuo Obinata and Akira Nakagawara. Their work appears in journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.